MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,792 | -2.6% | 19,002 | +40.8% | 0.04% | +2.6% |
| Q2 2023 | $312,860 | +14.3% | 13,497 | +14.5% | 0.04% | +8.6% |
| Q1 2023 | $273,789 | +12.5% | 11,786 | -29.8% | 0.04% | +12.9% |
| Q4 2022 | $243,449 | +19.9% | 16,778 | +57.9% | 0.03% | +6.9% |
| Q3 2022 | $203,000 | -3.8% | 10,629 | -8.5% | 0.03% | +3.6% |
| Q2 2022 | $211,000 | -10.6% | 11,619 | +23.9% | 0.03% | +3.7% |
| Q1 2022 | $236,000 | -3.7% | 9,378 | +5.7% | 0.03% | -3.6% |
| Q4 2021 | $245,000 | +8.4% | 8,875 | +26.9% | 0.03% | -3.4% |
| Q3 2021 | $226,000 | -9.6% | 6,996 | -14.5% | 0.03% | -12.1% |
| Q2 2021 | $250,000 | +3.3% | 8,184 | +3.1% | 0.03% | -10.8% |
| Q1 2021 | $242,000 | +1.7% | 7,936 | -34.0% | 0.04% | -30.2% |
| Q4 2020 | $238,000 | +44.2% | 12,028 | -4.8% | 0.05% | +17.8% |
| Q3 2020 | $165,000 | +194.6% | 12,636 | +681.4% | 0.04% | -6.2% |
| Q4 2017 | $56,000 | – | 1,617 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |